By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endo Pharmaceuticals 

100 Endo Boulevard

Chadds Ford  Pennsylvania  19317  U.S.A.
Phone: 610-558-9800 Fax: 610-558-8979



Company News
Endo Pharma (ENDP) Issues Voluntary Nationwide Recall For One Lot Of Edex (Alprostadil For Injection) 10 Mcg 2 Pack Carton Due To Potential Lack Of Sterility Assurance 2/27/2017 6:25:52 AM
BioDelivery (BDSI) Closes Transaction To Reacquire License To BELBUCA From Endo Pharma (ENDP) 1/9/2017 8:41:57 AM
BioDelivery (BDSI) Reacquires License To BELBUCA From Endo Pharma (ENDP) 12/8/2016 8:49:15 AM
Endo Pharma (ENDP) Presents New Phase 2 Data Evaluating The Safety And Effectiveness Of XIAFLEX (Collagenase Clostridium Histolyticum) For Dupuytren's Disease Nodules 9/30/2016 8:16:49 AM
Endo Pharma (ENDP) Announces FDA Advisory Committee Meeting For OPANA ER 6/15/2016 9:45:17 AM
Investors Concerned as Endo Pharma (ENDP) Mimics the Path of Valeant (VRX) 5/9/2016 6:44:45 AM
Endo Pharma (ENDP) to Cut 740 Employees and Shakes Up U.S. Senior Management in Restructuring 5/6/2016 6:08:50 AM
FTC Sues Endo Pharma (ENDP) for Allegedly Paying Off Generic Drugmakers 4/1/2016 6:49:29 AM
BioDelivery (BDSI) Announces The Launch Of BELBUCA (buprenorphine) Buccal Film By Endo Pharma (ENDP) For Chronic Pain Management 2/22/2016 10:50:17 AM
Endo Pharma (ENDP) To Announce Fourth Quarter 2015 Financial Results On February 29, 2016 2/16/2016 10:16:05 AM